Founded in 2019, Genexis Biotech operates in Health Tech offering 100% animal-origin-free solutions for healthcare, research, and related fields. Based in Vadodara, Gujarat, the company manufactures a...
Funding stage:
Seed
Last funding:
28/07/2025
Total funding:
$457.00K+
Revenue:
Investors
Employee count:
13
Last 90d
13
Last 90d
Web traffic:
3.7K
3.7K
Last 30d
Last 30d
Genexis Biotech: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders5
Latest Filing Date21 Oct 2024- Funding Events11
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Genexis Biotech
As of 22 October 2024, Genexis Biotech's equity is held by 4 shareholders, with the top three being Jitendra Wagh, Vipul Kumar, and Benzai10 Investment Ventures Private Limited.
Jitendra Wagh holds the largest stake in Genexis Biotech at 41.5% as of 22 October 2024.
As of 22 October 2024, founders collectively hold 83.1% equity in Genexis Biotech.
As of 22 October 2024, investors collectively hold 7.5% equity in Genexis Biotech.
Genexis Biotech's ESOP pool stands at 9.4% of total equity as of 22 October 2024.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links